Nshuti bakiriya bafite agaciro:
Mugihe icyorezo cya SARS-CoV-2 kigenda gitera imbere, ihinduka rishya n’imiterere ya virusi bikomeje kugaragara, bikaba bidasanzwe.Kugeza ubu, icyibandwaho ni impinduka ziva mu Bwongereza no muri Afurika y'Epfo zishobora kwandura indwara, kandi ikibazo ni ukumenya nibaibizamini bya antigen byihuseirashobora kandi kumenya ihinduka ryimiterere.
Dukurikije iperereza ryacu, ihinduka ryinshi ryibibanza ryabaye kuri poroteyine ya spike ku mwanya wa N501Y, E484K, K417N kuri SA mutant 501Y.V2, na N501Y, P681H, 69-70 kuri mutant mutant yo mu Bwongereza b.1.1.7 (Kuva Intara ya Guangdong ishinzwe kurwanya no gukumira indwara).Kubera ko kumenyekanisha ibikoresho fatizo bikoreshwa mugupimisha antigen ari proteine nucleocapsid itandukanye na site ya mutation, Iyi poroteyine iherereye hejuru ya virusi kandi irasabwa kugirango virusi yinjire mu kagari.
Nyamara, Testsealabs COVID-19 Antigen Rapid Ikizamini gipima indi poroteyine ya virusi, yitwa proteine nucleocapsid, iri muri virusi kandi ntigihindurwa na mutation.Rero, ukurikije uko siyanse igeze ubu, iyi variant irashobora kandi gutahurwa na Testsealabs COVID-19 Ikizamini cya Antigen Rapid.
Hagati aho, tuzahita tumenyesha amakuru yose yerekeranye na SARS-CoV-2Antigen Yihuta Yibikoresho.Mubyongeyeho, tuzakomeza imbaraga zacu kugirango twubahirize hejuruubuziranenge bwo gucunga neza no gukomeza gahunda ihamye yo gucunga neza ubuziranenge kugirango abakiriya bashimishwe n’umutekano w’ibicuruzwa.Niba ufite ikibazo, nyamuneka hamagara uhagarariye ibicuruzwa byacu.
Hangzhou Testsea Biotechnology Co, Ltd.
Igihe cyo kohereza: Mutarama-21-2021